Novel Anti-Silicone Surface-Associated Antigen Antibodies (Anti-SSAA(x)) May Help Differentiate Symptomatic Patients with Silicone Breast Implants from Patients with Classical Rheumatological Disease
The frequency of novel autoreactive antibodies to silicone surface associated antigens (anti-SSAA(x)) was measured in healthy control patients, symptomatic patients with breast implants, asymptomatic patients with breast implants, and control patients with classical rheumatological diseases. The frequencies of elevated anti-SSAA(x) antibodies in 310 symptomatic breast implant patients were 17.4% anti-SSAA(fn), 12.9% anti-SSAA(coll), and 7.4% anti-SSAA(col3) and 7.1% anti-SSAA(fbgn) [Normal (n=173) = 0.6% for all four tests] (p>.005). In 11 asymptomatic breast implant patients, the frequencies of elevated values for the same anti-SSAA’s were 0%, 9%, 0%, and 0% respectively, while in 50 patients with rheumatoid arthritis, the frequencies were 4%, 0%, 6% and 2% respectively. The anti-SSAA(x) profile for symptomatic patients with breast implants was different than the profile for control healthy patients (p>.005 on all eight tests) but differed significantly by two measures, anti-SSAA(fbgn) and anti-SSAA(col3), from the profile for the 19 patients with systemic lupus erythematosus. We conclude that anti-SSAA(x) antibodies levels in symptomatic patients with breast implants are elevated, that the antibodies are associated with symptoms, and that they differ both qualitatively and quantitatively from healthy controls, asymptomatic patients with breast implants, and symptomatic patients with classical rheumatological diseases.
KeywordsArthritis Syringe Bicarbonate Polyacrylamide Polystyrene
Unable to display preview. Download preview PDF.
- 2.Farber E.Textbook of Pathology, WB Saunders, New York, 1994.Google Scholar
- 4.Kossovsky N, Gornbein JA, Zeidler M, Stassi J, Chun G, Papasian N, Nguyen A, Ly K, Rajguru S: Self reported signs and symptoms in breast implant patients with novel antibodies to silicone-surface-adsorbed antigens (anti-SSAA). J Appl Biomat 1995 IN PRESSGoogle Scholar
- 5.Kossovsky N, Heggers JP, Robson MC. The bioreactivity of silicone. In: Williams DF, Ed CRC Critical Reviews in Biocompatibility. Boca Raton: CRC Press; 1987: 3:53–85.Google Scholar
- 9.Grisolia JS, Herndon R, Ostermeyer-Shoaib B, Lezak M, Prange R, and Boksenbaum S. spectrum of atypical neurology disease and cognitive disorders panels. Presented at the Silicone Related Disorders Study Group Workshop, New Orleans, 21-22 April 1995.Google Scholar
- 10.Silverman S, Berenson J, Silver D, Vescio R and Persselin J. Multiple myeloma. Two case histories and the incidence of increased immunoglobulin and monoclonal gammopathy in women with silicone breast implants. Presented at the NCI/NIH Workshop on the Immunology of Silicones, Bethesda, 13-14 March 1995.Google Scholar
- 11.Bernstein, RA: Humoral autoimmunity in systemic rheumatic disease. A review. J Roy Coll Phys (London) 1990; 24:18–25.Google Scholar
- 14.Tennenbaum SA, Cuellar ML, Citera G, Silveira LH, Garry RF and Espinoza LR. Presented at the annual meeting of American College of Rheumatology, San Antonio, TX, November, 1993. Abstract published in Arthritis & Rheumatism 1993;36:S118,A123.Google Scholar